Bristol-Myers Sales, Profit Beat Estimates

Bristol-Myers Squibb Co. reported a smaller-than-expected decline in third-quarter revenue, despite lost sales as the result of the pharmaceutical company’s exit of a diabetes alliance earlier this year.



from WSJ.com: US Business http://ift.tt/1xhdgPt

via IFTTT